Elkeles will serve through the 2027 annual Shareholder meeting and receive compensation under the company’s non-employee director programme.
PETMED EXPRESS expanded its board to 5 directors by appointing Tamar Elkeles as an independent director effective September 17, 2026. Investors gain a board member assigned to compensation, human capital, governance and nominating committees, with the company citing her executive, advisory and board experience in strategic oversight.
Key Highlights
- Tamar Elkeles joined PETMED EXPRESS as an independent director effective September 17, 2026.
- Her appointment increased the board’s size to 5 directors.
- Elkeles received 49,923 shares at $0 in connection with her insider position.
Tamar Elkeles became a director effective September 17, 2026, lifting the board to 5 members and adding an independent director with experience across technology, enterprise software and Human Capital industries.
Elkeles will remain on the board until the 2027 annual shareholder meeting, unless she resigns or is removed earlier, or a successor is elected and qualified. Nasdaq listing standards and the company’s Corporate Governance Guidelines classify her as independent. She will immediately serve on the Compensation and Human Capital Committee and the Corporate Governance and Nominating Committee. A separate insider transaction record shows an award of 49,923 PETMED EXPRESS (NASDAQ: PETS) shares at $0. The appointment carries compensation under PETMED EXPRESS’s Non-Employee Director Compensation Program. The company also intends to enter an indemnification agreement with Elkeles using the same form as its standard agreement with other directors. Her current board roles include Brightline Interactive (NASDAQ: BTLN) and OpenSesame.
FAQs
Q: Who is the new independent director at PETMED EXPRESS?
A: Tamar Elkeles is PETMED EXPRESS’s new independent director. She joined the board effective September 17, 2026, and was assigned to two board committees.
Q: How many directors are now on the PETMED EXPRESS board?
A: The PETMED EXPRESS board now has 5 directors. The increase followed Tamar Elkeles’s appointment as an independent director.
Q: How long will Tamar Elkeles serve on the PETMED EXPRESS board?
A: Elkeles will serve until the 2027 annual meeting of shareholders. Her term can end earlier through resignation or removal, or when a successor is elected and qualified.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.